The National Institutes of Health said today that it’s launching a huge research study with the aim of making precision medicine available to people of all backgrounds.
Background: President Obama first announced the program back in 2015 to realize the dream of precision medicine—that is, tailoring health care to an individual’s genetics, lifestyle, and environment. It’s been in beta testing for the past year, and so far about 25,000 participants have joined.
Diverse data: In a briefing with reporters, NIH officials said they are focusing on gathering health and genetic data from diverse and historically underrepresented groups—including ethnic and sexual minorities, as well as people with disabilities, with less than a high school education, and with income below the poverty level. NIH is hosting events in diverse communities around the country to sign people up.
Next steps: Dubbed All of Us, the program will begin sequencing participants’ genomes later this year. The goal is to enroll a million participants who will share health information about themselves, through means including surveys and electronic health records, with researchers over the 10 years of the program.
Biotechnology and health
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Some deaf children in China can hear after gene therapy treatment
After deafness treatment, Yiyi can hear her mother and dance to the music. But why is it so noisy at night?
Scientists just drafted an incredibly detailed map of the human brain
A massive suite of papers offers a high-res view of the human and non-human primate brain.
Three people were gene-edited in an effort to cure their HIV. The result is unknown.
CRISPR is being used in an experimental effort to eliminate the virus that causes AIDS.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.